← Leaderboards
Donald D Muccio
University Of Alabama At Birmingham
$2,766,715
Attributed
$2,766,715
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $402.6K · FY2007–19$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,766,715 · 4
By mechanism
P50$1,948,370 · 2
P01$481,904 · 1
R01$336,441 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Peter D Emanuel$39,860,242
- Craig A Elmets$8,601,504
- Jeevan Kumar Prasain$1,001,113
- Bernard Roizman$20,026,247
- Muhan Hu$132,140
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionRetinoidsClinical ResearchReceptorProgramsOralPreventionGenerationsMammary NeoplasmsMalignant NeoplasmsPreventNamesAgonistCancer PreventionDesignMouse ModelDoseDose-LimitingBexaroteneIn VitroIn VivoLipidsNuclear ReceptorsPreventive
Grant awards (12)
Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents$207,303
P01 · FY2019 · CA · contact PI
Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents$59,920
P01 · FY2019 · CA · contact PI
Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents$214,681
P01 · FY2017 · CA · contact PI
UAB Rexinoids for Breast Cancer Prevention$383,363
P50 · FY2011 · CA · contact PI
UAB Rexinoids for Breast Cancer Prevention$402,626
P50 · FY2010 · CA · contact PI
UAB Rexinoids for Breast Cancer Prevention$401,679
P50 · FY2009 · CA · contact PI
UAB Rexinoids for Breast Cancer Prevention$378,919
P50 · FY2008 · CA · contact PI
UAB Rexinoids for Breast Cancer Prevention$381,783
P50 · FY2007 · CA · contact PI
PRECLINICAL/CLINICAL DEVELOPMENT OF NOVEL RETINOIDS$0
P50 · FY2002 · CA
PRECLINICAL/CLINICAL DEVELOPMENT OF NOVEL RETINOIDS$0
P50 · FY2001 · CA
NOVEL RETINOIDS FOR LEUKEMIA THERAPY$336,441
R01 · FY2000 · CA
PRECLINICAL/CLINICAL DEVELOPMENT OF NOVEL RETINOIDS$0
P50 · FY2000 · CA